Shalini Singh Yadav

8PUBLICATIONS
89CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer.

Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel

|May 20, 2024
Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis.

Bilal A Siddiqui, Nicolas L Palaskas, Sreyashi Basu

|Apr 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav

|Jan 20, 2023
Epigenetic-Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer.

Chandrima Das, Swagata Adhikari, Apoorva Bhattacharya

|Apr 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.

Pavlos Msaouel, Sangeeta Goswami, Peter F Thall

|Jun 30, 2021
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan

Pageof 2

Frequent Collaborators

6 joint publications

James P Allison

5 joint publications

Padmanee Sharma

5 joint publications

Sreyashi Basu

3 joint publications

Sonali Jindal